Medical Research Future Fund (MRFF)

What Medical Research Future Fund (MRFF) does

The Medical Research Future Fund (MRFF) is an Australian Government long-term investment fund established in 2015 and administered by the Department of Health, Disability and Ageing. Its stated purpose is to support Australian health and medical research through competitive grant programs, with a total fund value exceeding AUD 25 billion and a government commitment to lift annual disbursements to AUD 1 billion by 2030-31. The Australian Medical Research Advisory Board (AMRAB), chaired by Professor Kathryn North AC, sets the fund's strategic priorities on a five-year cycle and focus areas every two years, with the most recent consultation covering the 2026-2031 Strategy and 2026-2028 Priorities.

MRFF operates as a portfolio of grant initiatives and research missions rather than a unified product. The portfolio includes flagship missions (Australian Brain Cancer Mission, Genomics Health Futures Mission, Million Minds Mental Health Research Mission, Cardiovascular Health Mission, Dementia/Ageing and Aged Care Mission, Stem Cell Therapies Mission, Traumatic Brain Injury Mission) and targeted initiatives (Frontier Health and Medical Research, Clinical Trials Activity, Preventive and Public Health Research, Indigenous Health Research Fund, Biomedical Translation Bridge, Rapid Applied Research Translation, National Critical Research Infrastructure, Research Data Infrastructure, and Medical Research Commercialisation). Grant recipients are drawn from Australian universities, hospitals, medical technology companies, and Aboriginal Community Controlled Health Organisations, with applications submitted through the GrantConnect portal.

The fund distributes capital via competitive grants rather than generating revenue from product sales, making it a non-dilutive funding source for Australian researchers. In 2025-2026, MRFF awarded notable grants including AUD 21.5 million to the University of Queensland, AUD 18 million to AdvanCell under the Frontiers Initiative for targeted alpha therapy, AUD 5 million to Flinders University for antimicrobial resistance research in remote Northern Territory, and AUD 3.7 million to Monash University's Victorian Heart Institute for the PUMA clinical trial. Despite the fund's size, over AUD 1 billion remains undistributed due to government spending caps, and the fund has been criticised for slow disbursement relative to its endowment.

Name

Medical Research Future Fund (MRFF)

Legal name

Medical Research Future Fund (MRFF)

Website

https://www.health.gov.au/our-work/mrff

Company type

Public

Operating status

Operating

Short description

The Medical Research Future Fund (MRFF) is a Australian Government long-term investment fund valued at over AUD 25 billion that distributes competitive grants to universities, hospitals, and medical technology companies for health and medical research. It is administered by the Department of Health, Disability and Ageing under AMRAB oversight.

Ownership category

akta.pro rank

Product category

Government Medical Research Grants

NAICS

Voluntary Health Organizations (813212)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Public Health Financing, Budgeting & Grants Management (HLAJAMAC), Grantmaking & Philanthropic Funds (Institutional Donors) (BPADAOAB)

Keywords

• Medical research funding
• Government health grants
• Clinical research grants
• Translational medicine funding
• Public health investment

Headquarters

HQ city

Australia

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Technology or R&D, Personnel, Others

Revenue model

1. Government Medical Research Funding: MRFF operates as a long-term investment fund supporting Australian health and medical research. The fund has reached over $25 billion and distributes grants through competitive grant opportunities to researchers, universities, and healthcare institutions across Australia.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

The MRFF is a $25.4 billion Australian Government long-term investment fund that finances health and medical research through competitive grant programs. It disburses funds to Australian universities, research institutions, hospitals, and medical technology companies via a portfolio of themed research missions and cross-cutting research initiatives. Grant applications are submitted through GrantConnect and awarded against strategic priorities set every five years (and focus areas every two years) by the Australian Medical Research Advisory Board (AMRAB).

Product overview

The Medical Research Future Fund (MRFF) is a $25.4 billion Australian Government long-term investment supporting health and medical research. Rather than a unified software product, MRFF operates as a portfolio of competitive grant programs and research missions that fund Australian researchers. The MRFF encompasses multiple distinct initiatives including the Australian Brain Cancer Mission, various research missions (Genomics Health Futures, Million Minds Mental Health, Cardiovascular Health, Dementia/Aged Care, Stem Cell Therapies, Traumatic Brain Injury), and research initiatives (Accelerated Research, Frontier Health and Medical Research, Clinical Trials Activity, Preventive and Public Health Research, Indigenous Health Research). Research institutions, universities, and hospitals apply for grants to conduct medical research, with funding allocated through grant opportunities managed via GrantConnect.

Differentiator

Problem solved

Functional benefit

Brands

• MRFF Frontiers Initiative: A flagship funding initiative under MRFF supporting breakthrough medical research with significant investment in transformative research programs.

Products and services

• Medical Research Future Fund (MRFF) A $25.4 billion Australian Government long-term investment supporting health and medical research through competitive grant funding distributed to Australian universities, research institutes, hospitals and medical technology companies.
• Australian Brain Cancer Mission MRFF research mission focused on accelerating brain cancer research through targeted funding and collaborative research programs for Australian researchers and institutions.
• Emerging Priorities and Consumer-Driven Research initiative MRFF 10-year Investment Plan initiative supporting researchers working to develop new treatments and cures for debilitating conditions in areas of identified unmet need (consolidated successor to the Accelerated Research Initiative).
• Frontier Health and Medical Research initiative MRFF initiative supporting groundbreaking frontier health and medical research with potential for transformative impact (host program of the MRFF Frontiers Initiative, including the $18 million AdvanCell award).
• Clinical Trials Activity initiative MRFF initiative supporting clinical trials activity across Australia, including trials such as the PUMA clinical trial at Monash University's Victorian Heart Institute.
• Genomics Health Futures Mission MRFF mission focused on advancing genomics research for improved health outcomes across Australia.
• Million Minds Mental Health Research Mission MRFF mission supporting mental health research with the goal of engaging one million Australians in mental health research.
• Cardiovascular Health Mission MRFF mission focused on improving cardiovascular health outcomes through targeted research funding, including cardiovascular health programs for First Nations communities.
• Dementia, Ageing and Aged Care Mission MRFF mission addressing research needs in dementia, ageing and aged care across Australia.
• Stem Cell Therapies Mission MRFF mission advancing stem cell therapies research for blood cancers and other conditions (e.g., University of Queensland stem cell therapies for blood cancers project).
• Traumatic Brain Injury Mission MRFF mission focused on research to improve outcomes for Australians affected by traumatic brain injury.
• Preventive and Public Health Research initiative
• Indigenous Health Research Fund MRFF fund supporting health research specifically for Aboriginal and Torres Strait Islander communities (e.g., Kirby Institute / NACCHO-led point-of-care testing at 30 sites nationwide).
• Biomedical Translation Bridge initiative MRFF initiative supporting the translation of biomedical research into health outcomes.
• Rapid Applied Research Translation initiative MRFF initiative supporting rapid translation of applied research into practice.
• National Critical Research Infrastructure initiative MRFF initiative supporting national research infrastructure capabilities across Australia.
• Research Data Infrastructure initiative MRFF initiative supporting research data infrastructure development across Australia.
• Medical Research Commercialisation initiative MRFF initiative supporting the commercialisation of medical research outcomes in Australia.

Quantifiable outcome

• University of Queensland researchers secured $21.5 million for cancer, arthritis, and Alzheimer's research including stem cell therapies and vaccine development
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core.

• University of QueenslandcoreStrategic or Co-development Partner · 20 July 2026University of Queensland researchers received $21.5 million from MRFF across four grant schemes for medical research including stem cell therapies for blood cancers, Alzheimer's treatment research using Lion's mane mushrooms, psoriatic arthritis treatment, and cardiovascular health programs for First Nations communities. Ten researchers will work on these projects with funding supporting research infrastructure including a digital decision-support platform and vaccine development pipeline.
• Flinders UniversitycoreStrategic or Co-development Partner · 7 July 2026Flinders University researchers received nearly $5 million from MRFF for the 'Tackling Antimicrobial Resistance in Remote Australia' (TARRA) project. The project targets the fact that 26% of antimicrobial prescriptions in remote primary healthcare clinics are unsuitable, with AMR rates up to four times the national average. Led by Dr Danny Tsai, the project will develop surveillance tools, virtual clinical support, and culturally-appropriate health promotion.
• Monash University (Victorian Heart Institute)coreStrategic or Co-development Partner · 22 January 2026Monash University's Victorian Heart Institute received $3.7 million MRFF grant for the world-first PUMA clinical trial. The trial compares traditional invasive pulmonary artery catheters (PAC) with a simpler central venous catheter (CVC) alternative for monitoring open-heart surgery patients. Co-designed with patients and families.
• Kirby Institute at UNSW SydneycoreStrategic or Co-development Partner · 2 January 2026The Kirby Institute at UNSW Sydney is leading an MRFF-funded initiative to expand point-of-care infectious disease testing for First Nations people in rural and remote Australia. The project tests for Strep A (preventing acute rheumatic fever) and HPV (preventing cervical cancer) at 30 sites nationwide.
• National Aboriginal Community Controlled Health Organisation (NACCHO)coreStrategic or Co-development Partner · 2 January 2026Co-led the MRFF-funded point-of-care testing initiative with the Kirby Institute. The program was co-designed with Aboriginal and Torres Strait Islander communities and incorporates community-led governance to ensure culturally safe, sustainable healthcare delivery at 30 sites nationwide.
• AdvanCellcoreStrategic or Co-development Partner · 14 April 2025AdvanCell was awarded $18 million from MRFF Frontiers Initiative for targeted alpha therapy research targeting prostate cancer. The program leverages the company's proprietary Lead-212 (212Pb) alpha isotope production technology. The multi-institutional program involves collaborations with clinical investigators from Australian hospitals and universities.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• National Health and Medical Research Council (NHMRC): Australia's other major government medical research grantmaker, also disbursing competitive federal funding to universities, hospitals and institutes. NHMRC is the closest analogue to MRFF, with the two funds historically set up to be complementary but both serving the same Australian researcher base through government-administered grant schemes.
• Canadian Institutes of Health Research (CIHR): Canada's federal health research funding agency, structured as a government arm's-length body that funds investigator-initiated and priority-driven research. CIHR is a near-direct structural analogue to MRFF and a useful cross-jurisdiction benchmark for funding scale and disbursement pace.
• European Research Council (ERC): Pan-European public funding body supporting frontier research through competitive grants across member states. ERC is structurally comparable as a government-backed competitive research funder with strategic priority cycles, even though its scope extends beyond health to all sciences.

Broad incumbents

• National Institutes of Health (NIH): The largest government medical research funding body globally, distributing tens of billions annually to intramural and extramural researchers. NIH is comparable in mission (federal funding of biomedical research across disease areas) but operates at far larger scale and broader scope than MRFF.
• UK Research and Innovation (UKRI): UK government body that funds research and innovation including the Medical Research Council. UKRI is structurally comparable as a government research funder with a long-term investment portfolio and competitive grant programs, though its mandate is far broader than medical research alone.
• Wellcome Trust: One of the world's largest charitable foundations funding health and medical research, including major translational and discovery programs globally. Comparable to MRFF in driving a portfolio of large-scale biomedical research initiatives, but operating as a private endowed charity rather than a government fund.
• Bill & Melinda Gates Foundation: Major philanthropic funder of global health and biomedical R&D across infectious disease, maternal and child health, and translational science. Overlaps with MRFF on the strategic role of large-scale grantmaking in advancing health research, though with a global health and disease-burden focus distinct from MRFF's domestic mandate.
• Howard Hughes Medical Institute (HHMI): Large US-based biomedical research organization funding investigator-led science, translational programs, and research infrastructure. HHMI is comparable as a long-duration, mission-driven medical research funder with a portfolio of programs analogous to MRFF's missions.

Regional players

• Health Research Council of New Zealand (HRC): New Zealand's primary government health research funding agency, distributing competitive grants to researchers and institutions across the country. HRC is a strong structural analogue in a geographically distinct jurisdiction, useful as a benchmark for disbursement cadence in a small research system.

Others

• Health Canada / Public Health Agency of Canada grant programs: Federal Canadian funding streams that co-fund health research alongside CIHR, including targeted public health and population health grants. Comparable as government-managed health research financing vehicles, though more distributed across multiple agencies than MRFF's consolidated fund.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/healthgovau
• YouTubeyoutube.com/user/healthgovau
• Facebookfacebook.com/healthgovau
• LinkedInau.linkedin.com/company/dept-of-health-and-ageing
• Instagraminstagram.com/healthgovau

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments24 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Research Future Fund (MRFF)